Information Provided By:
Fly News Breaks for September 19, 2016
MOH
Sep 19, 2016 | 06:04 EDT
Goldman Sachs analyst Matthew Borsch upgraded Molina Healthcare to Neutral saying risk of another significant earnings miss is lower following the Q1 shortfall. The analyst expects investors to now focus on 2017-2018 growth. He upped his price target for the shares to $58 from $51.